ArticleMetabolites2025

A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability.

Afoke Ibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.